Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.
Panretin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2002
Highly Cited
2002
Rexinoids binding to both the retinoic acid receptor (RAR) and retinoid X receptor (RXR) families of rexinoid receptors have… Expand
Highly Cited
2002
Highly Cited
2002
Objective To assess the efficacy, safety and tolerance of oral 9-cis- retinoic acid in HIV-infected patients with Kaposi's… Expand
Review
2001
Review
2001
This review focuses on the use of alitretinoin (Panretin) gel 0.1% therapy as a new topical treatment of cutaneous lesions in… Expand
Highly Cited
1999
Highly Cited
1999
Background Kaposi's sarcoma (KS) is the most frequent malignancy in patients with HIV. Given the promise that retinoids show in… Expand
Highly Cited
1999
Highly Cited
1999
BACKGROUND
Kaposi's sarcoma (KS) is the most frequent malignancy in patients with HIV. Given the promise that retinoids show in… Expand
1999
1999
The Food and Drug Administration (FDA) recently enacted rules requiring drug companies to provide physicians with information… Expand
1998
1998
Ligand Pharmaceuticals is seeking the Food and Drug Administration's (FDA) approval of Panretin gel (9-cis retinoic acid) to… Expand